Participate in a Clinical Trial - National Multiple Sclerosis Society

Skip to navigation Skip to content

Participate in a Clinical Trial

Research volunteers are critical for progress.

Share

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

  1. Clinical Trial: Gilenya® capsules (fingolimod, Novartis Pharmaceuticals AG) versus Copaxone® (glatiramer acetate, Teva Pharmaceutical Industries, Ltd.

    A 12-month, randomized, blinded study to compare the effectiveness and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing-remitting MS. 
  2. Clinical Trial: RPC1063 (Receptos, Inc.)

    To determine safety and effectiveness of RPC1063, a selective sphingosine 1-phosphate receptor modulator, in people with relapsing MS.
  3. Clinical Trial: Home-based exercise training

    Project GET FIT with MS: Guidelines for Exercise Training and Fitness outcomes in MS: University of Illinois researchers invite you to participate in a voluntary study on AT HOME exercise training for people with multiple sclerosis
  4. Clinical Trial: Home-Based Fall Prevention Program

    To examine the effectiveness of a home-based exercise program, an educational program and their combination on minimizing falls and fall risk.
  5. Clinical Trial: Home based exercise training for people living with MS

    Testing a home-based exercise program in women with MS between ages of 18-54 or men with MS between 18-44, who are relapse free in the past 30 days, can walk without assistance, are non-exercisers and have medical clearance for exercise testing, and are willing to visit the Un...
  6. Clinical Trial: Estriol

    A double-blind, placebo controlled trial to determine whether estriol treatment (added on to standard therapies) improves cognition in women with multiple sclerosis.
  7. Clinical Trial: Aubagio® (teriflunomide, Genzyme, a Sanofi Company)

    An open-label study for patients with relapsing multiple sclerosis. to evaluate overall satisfaction of Aubagio® treatment including effectiveness, tolerability, convenience, and improvement from disease progression from patient point of view through the evaluation of Ques...
  8. Clinical Trial: ibudilast (MN-166, MediciNova, Inc.)

    A multicenter, randomized, double-blind, placebo-controlled, parallel-group study designed to evaluate the safety, tolerability and activity of ibudilast administered twice daily over a 96 week period in subjects with primary or secondary progressive multiple sclerosis. ...
  9. Clinical Trial: Ballroom dance for persons with MS

    Pilot/Feasibility study to determine if partnered social dancing (i.e., ballroom dance) improves balance, stress, fatigue, or otherwise quality of life in persons with MS compared to a non-dance MS control group.
  10. Clinical Trial: New investigational dosage of approved medication for urinary incontinence

    A double blind, placebo controlled, parallel assignment study to evaluate the safety and effectiveness of new investigational dosage of approved medication, which is injected into the bladder muscle to treat urinary incontinence in people with MS.

Share


Clinical Trial Alerts

Sign up for MS Trial Alerts

Find out about new studies recruiting people with MS.

View Alerts

View Alerts

Clinical Trials in MS


The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

Read more

Read more

NARCOMS Patient Registry

This registry of people willing to participate in MS research was initiated by the Consortium of MS Centers to facilitate multicenter studies. As of May 2007, the number of participants surpassed 37,000. Information is available in Spanish. Read more about Narcoms here or visit the website by clicking below.

Visit NARCOMS

Visit NARCOMS

Learn About Clinical Trials

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Contact Us

Contact Us
Newly Diagnosed
If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Start Here